CheckMyRecalls

Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral…

Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution

Published
14 Oct 2026
Units affected
N/A
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only, Manufactured by: Cipla Ltd., Kurkumbh-413802, Maharashtra, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-579-67.

Brand / company
Cipla USA, Inc.
Codes / lots
Lot#: 5KA0405, Exp 12/31/2026.
Distribution
USA Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 14 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.